Shenzhen Edge Medical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	279.13	159.99	48.04
Revenue Growth (YoY)	-	233.03%	-
Cost of Revenue	125.48	81.03	43.48
Gross Profit	153.65	78.96	4.56
Selling, General & Admin	157.33	134.72	100.23
Research & Development	227.19	226.25	171.23
Operating Expenses	388.76	362	272.01
Operating Income	-235.11	-283.04	-267.44
Interest Expense	-0.7	-0.86	-0.99
Interest & Investment Income	5.94	5.22	5.36
Currency Exchange Gain (Loss)	-0.37	-0.12	0.18
Other Non Operating Income (Expenses)	31.2	30.71	3
EBT Excluding Unusual Items	-199.11	-248.09	-259.89
Gain (Loss) on Sale of Investments	25.53	31.02	47.02
Asset Writedown	-1.43	-1.43	-
Pretax Income	-175.01	-218.51	-212.87
Net Income	-175.03	-218.51	-212.87
Net Income to Common	-175.03	-218.51	-212.87
Shares Outstanding (Basic)	360	360	360
Shares Outstanding (Diluted)	360	360	360
EPS (Basic)	-0.49	-0.61	-0.59
EPS (Diluted)	-0.49	-0.61	-0.59
Free Cash Flow	-192.01	-251.03	-381.64
Free Cash Flow Per Share	-0.53	-0.70	-1.06
Gross Margin	55.05%	49.35%	9.49%
Operating Margin	-84.23%	-176.91%	-556.69%
Profit Margin	-62.70%	-136.57%	-443.09%
Free Cash Flow Margin	-68.79%	-156.90%	-794.39%
EBITDA	-215.67	-264.82	-259.09
EBITDA Margin	-77.26%	-165.52%	-
D&A For EBITDA	19.44	18.22	8.36
EBIT	-235.11	-283.04	-267.44
EBIT Margin	-84.23%	-176.91%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.